The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has recently published a new version of its Code of Practice. The new code, which updates the current 2012 code, will come into force on 1st January 2019.
The principle changes to the code relate to the code’s underlying values, and the sections relating to gifts. A new ‘Code Ethos’, which replaces the old code’s guiding principles, aims to put patient trust at the centre of the code. The IFPMA hopes that this change will allow members to be more flexible, and apply values to scenarios that are not explicitly covered by the rules. The four foundations which the ethos is built on are care, fairness, honesty and respect.
The new code also limits the scenarios in which the general ban on items which “constitute an inducement to prescribe, recommend, purchase, supply, sell or administer a pharmaceutical product” does not apply. ‘Social courtesy gifts’ and ‘promotional gifts of more than minimal value or quantity’ are no longer permitted.
IFPMA members, which include the EFPIA and PhRMA, have until the 1st January 2019 to update their own codes to reflect this guidance. To read the IFPMA’s summary of the changes to the code, click here: